Clinical Trials Using Anti-EGFR Monoclonal Antibody ABT-806
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-EGFR Monoclonal Antibody ABT-806. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Personalized Antibodies in Treating Patients with Metastatic Stomach or Gastroesophageal Junction Cancer
This pilot phase II trial studies personalized antibodies in treating patients with stomach or gastroesophageal junction cancer that has spread to other parts of the body. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies may block tumor growth in different ways by targeting certain cells. Testing tumor tissue for gene mutations and protein expression patterns and using drugs that target the specific profile of the tumor, may work better than standard chemotherapy in treating patients with stomach or gastroesophageal junction cancer.
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois